Product Details for NDA 018031
INDERIDE-40/25 (HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE)
25MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
25MG;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
25MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE
Proprietary Name: INDERIDE-40/25
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N018031
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: WYETH PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
INDERIDE-80/25 (HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE)
Proprietary Name: INDERIDE-40/25
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N018031
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: WYETH PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
25MG;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE
Proprietary Name: INDERIDE-80/25
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N018031
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: WYETH PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: INDERIDE-80/25
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N018031
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: WYETH PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information